entity

Ric

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Ric: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections
30Hypotheses
3Analyses
11Outgoing
2Incoming
14Experiments
3Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

LRRK2 — Leucine Rich Repeat Kinase 2

gene · 3823 words

Steele-Richardson-Olszewski Syndrome

disease · 2455 words

LRRK2 (Leucine-Rich Repeat Kinase 2) — Comprehensive Gene Review

gene · 2407 words

LRFN1 — Leucine Rich Repeat and Fibronectin Type III Domain Containing 1

gene · 2282 words

PSP Richardson Syndrome vs Corticobasal Syndrome: A Deep Comparison

mechanism · 1905 words

Outgoing (11)

TargetRelationTypeStr
Inflammationassociated_withprocess0.95
Oxidative Stressassociated_withprocess0.95
NFE2L2upregulatesprotein0.92
HO1upregulatesprotein0.92
IL1Bdownregulatesprotein0.90

Incoming (2)

SourceRelationTypeStr
34185099decreasedpaper0.90
34185099protectedpaper0.90

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
APOE4 Allosteric Rescue via Small Molecule Chaperones 0.765 neurodegeneration APOE4 structural biology and therapeutic
Circulating Soluble PDGFRβ Reflects Pericyte Loss and Preced 0.745 - What blood-brain barrier permeability ch
Seed-Proximal Asymmetric Duplex Stability Confers lncRNA-002 0.733 molecular neurobiology View
APOE4-driven pericyte injury/senescence is an upstream drive 0.720 neurodegeneration Does pericyte senescence drive BBB break
Bacterial Curli Amyloid → Nucleation of α-Synuclein Misfoldi 0.720 neurodegeneration What are the mechanisms by which gut mic
Soluble PDGFRβ as a Peripheral Indicator of Pericyte-Mediate 0.705 - What blood-brain barrier permeability ch
Pericyte-targeted senolysis or senomorphic therapy will bene 0.700 neurodegeneration Does pericyte senescence drive BBB break
Pericyte Contractility Reset via Selective PDGFR-β Agonism 0.684 neurodegeneration Perivascular spaces and glymphatic clear
Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neu 0.680 neurodegeneration What are the mechanisms by which gut mic
Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR- 0.662 - Blood-brain barrier permeability changes
Radiation drives pericyte senescence through lysosome acidif 0.652 neurodegeneration What specific autophagy pathways are def
Mitochondrial ATP/ADP Carrier Activity as Bioenergetic Recov 0.642 translational neuroscience Which metabolic biomarkers can distingui
Glycine-Rich Domain Competitive Inhibition 0.640 neurodegeneration TDP-43 phase separation therapeutics for
Amyloid-beta induces secondary pericyte senescence after con 0.640 neurodegeneration Does pericyte senescence drive BBB break
Caloric Restriction Mimetic Combination Therapy (Metformin + 0.640 neurodegeneration -
Enteric Nervous System Dysfunction as Self-Reinforcing Patho 0.630 neurodegeneration Gut-Brain Axis in Parkinson's Disease: M
Pericyte senescence is sufficient to weaken the BBB even wit 0.630 neurodegeneration Does pericyte senescence drive BBB break
Steric Occlusion of G3BP1 Oligomerization Interface 0.630 neurodegeneration How does TRIM21-mediated K63 ubiquitinat
APOE4-microglial complement signaling causes cholinergic-enr 0.630 neurodegeneration What determines the temporal sequence of
Circulating Soluble PDGFRβ Reflects Pericyte Loss and Preced 0.625 - What blood-brain barrier permeability ch
Serine/Arginine-Rich Protein Kinase Modulation 0.624 neurodegeneration TDP-43 phase separation therapeutics for
H7: Enteric Nervous System Alpha-Synuclein Propagation Block 0.620 neurodegeneration How does engineered C. butyricum cross t
Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro 0.613 neurodegeneration What are the mechanisms by which gut mic
CSF ApoE- and clusterin-rich lipoprotein particles stabilize 0.606 neurodegeneration Which specific CSF molecular components
whether the Mitochondrial transfer between neurons and glia 0.604 neurodegeneration Methodology challenge: notebook 'Mitocho
whether the Astrocyte reactivity subtypes in neurodegenerati 0.604 neurodegeneration Methodology challenge: notebook 'Astrocy
whether the Mitochondrial transfer between neurons and glia 0.604 neurodegeneration Methodology challenge: notebook 'Mitocho
Elevated Circulating sPDGFRβ Reflects Early Pericyte Loss Pr 0.600 - What blood-brain barrier permeability ch
Stratified falsifiers should govern Methodology challenge: n 0.591 neurodegeneration Methodology challenge: notebook 'Astrocy
Stratified falsifiers should govern Methodology challenge: n 0.591 neurodegeneration Methodology challenge: notebook 'Mitocho

Mentioning Analyses (3)

Scientific analyses that reference this entity

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-28 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.604

Experiments (14)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
GWAS of plasma NfL in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
GWAS of plasma pTau217 in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
Dairy intake and dementia risk in Malmö Diet and Cancer cohort clinical Alzheimer's disease 0.950 0.00 Swedish community-based adults proposed N/A
GWAS of plasma pTau181 in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
GWAS of plasma GFAP in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
KEEPS Continuation: Long-term effects of menopausal hormone therapy on clinical Alzheimer's disease 0.950 0.00 recently menopausal women with proposed N/A
GWAS of composite biomarker score exploratory Alzheimer's disease 0.900 0.00 human patients - East Asian co proposed N/A
RBG treatment in ApoE-/- atherosclerosis mouse model validation atherosclerosis 0.900 0.00 ApoE-/- mice proposed N/A
Irisin effects on angiogenesis in human endothelial cells exploratory bone fracture 0.900 0.00 human umbilical vein endotheli proposed N/A
APOE4 association with TDP-43 pathology in AD exploratory Alzheimer's disease 0.750 0.00 human patients proposed N/A
s:** - Biochemical binding assays measuring PROTAC selectivity for APO falsification Neurodegeneration 0.400 0.50 cell_line proposed $100,000
Proposed experiment from debate on Perivascular spaces and glymphatic falsification Neurodegeneration 0.400 0.50 cell_line proposed $100,000
Vascular Contribution to Alzheimer's Disease — Beyond Amyloid validation Alzheimer's Disease 0.400 0.50 human proposed $2,280,000
Vascular Contributions to Alzheimer Disease and Mixed Pathology clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of [PMID:30335591] Rusmini P, Cortese K, Crippa V, Cristofa Autophagy 2019 2
Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic [PMID:40848726] Zhao S, Li R, Xia Y, Wang X, Liu Z, Chu Cell Stem Cell 2025 1
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] Litvinchuk A, Suh JH, Guo JL, Lin K, Dav Neuron 2024 1
The cell biology of APOE in the brain. [PMID:37805344] Windham IA, Cohen S Trends Cell Biol 2024 1
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain dis [PMID:39526043] Kempuraj D, Dourvetakis KD, Cohen J, Val Front Cell Neurosci 2024 1
The Genetics of Primary Familial Brain Calcification: A Literature Review. [PMID:37446066] Chen SY, Ho CJ, Lu YT, Lin CH, Lan MY, T Int J Mol Sci 2023 1
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] Maxine R Nelson, Peng Liu, Ayushi Agrawa Nature neuroscience 2023 1
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmon [PMID:35257044] Calvier L, Herz J, Hansmann G JACC Basic Transl Sci 2022 1
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] Serrano-Pozo A, Das S, Hyman BT Lancet Neurol 2021 1
Decoding myofibroblast origins in human kidney fibrosis. [PMID:33176333] Kuppe C, Ibrahim MM, Kranz J, Zhang X, Z Nature 2021 1
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. [PMID:32376954] Montagne A, Nation DA, Sagare AP, Barisa Nature 2020 1
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] Long JM, Holtzman DM Cell 2019 1
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [PMID:31367008] Yamazaki Y, Zhao N, Caulfield TR, Liu CC Nat Rev Neurol 2019 1
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188] Cetindag AC, Schipke CG, Esselmann H, Kr The journal of prevention of A 2026 0
Pathophysiology of Primary Familial Brain Calcification. [PMID:41212990] Keller A Annual review of physiology 2026 0
ASS1 Promotes Atherosclerotic Inflammation Through the NLRP3/IL-33/ST2 Axis in O [PMID:41914296] Wu S, Han F, Qiao Z, Yuan S, Bian X, Zha Frontiers in bioscience (Landm 2026 0
A FZD4/LRP5 agonist restores pericyte coverage and vascular integrity by increas [PMID:41890033] Levey J, Howe M, Douglas K, Odame E, Raj bioRxiv : the preprint server 2026 0
Perioperative polygenic and APOE-based genetic risk assessment for neurocognitiv [PMID:40562635] Thedim M, Hu J, Maher M, Wiener-Kronish Br J Anaesth 2026 0
Increased genetic protection against Alzheimer's disease in centenarians. [PMID:40615639] Bae H, Song Z, Ali A, Sasaki T, Tesi N e Geroscience 2026 0
Integrative machine learning approach to risk prediction for dementia and Alzhei [PMID:40864401] Stern A, Linial M Geroscience 2026 0

Debates (3)

Multi-agent debates referencing this entity

Methodology challenge: notebook 'Astrocyte reactivity subtypes in neurodegenerat

active · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

active · Rounds: 4 · Score: 0.64 · 2026-04-28

Methodology challenge: notebook 'Mitochondrial transfer between neurons and glia

active · Rounds: 4 · Score: 0.64 · 2026-04-28

Related Research

Hypotheses and analyses mentioning Ric in their description or question text

Soluble PDGFRβ as a Peripheral Indicator of Pericyte-Mediated Blood-Brain Barrie

Score: 0.705 · unknown disease · 2026-04-26

Pericyte loss in Alzheimer's disease leads to proteolytic shedding of PDGFRβ into circulation, providing a blood-accessi

Pericyte-targeted senolysis or senomorphic therapy will benefit only an early bi

Score: 0.700 · neurodegeneration · 2026-04-25

Therapeutic benefit from pericyte-directed senescence interventions depends on stage. If BBB leak and dysfunction occur

Pericyte Contractility Reset via Selective PDGFR-β Agonism

Score: 0.684 · neurodegeneration · 2026-04-02

## Mechanistic Overview Pericyte Contractility Reset via Selective PDGFR-β Agonism starts from the claim that modulating

Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neurons

Score: 0.680 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The proposed mechanism centers on a complex interplay between gut microbiota,

Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR-β as Sentinel Event

Score: 0.662 · unknown disease · 2026-04-26

CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau path

Radiation drives pericyte senescence through lysosome acidification failure and

Score: 0.652 · neurodegeneration · 2026-04-25

Autophagosomes still form after irradiation, but damaged lysosomes cannot clear cargo, sustaining ROS and SASP output.

Mitochondrial ATP/ADP Carrier Activity as Bioenergetic Recovery Metric

Score: 0.642 · translational neuroscience · 2026-04-16

## **Molecular Mechanism and Rationale** The adenine nucleotide translocator (ANT), encoded by the SLC25A4 gene and als

Glycine-Rich Domain Competitive Inhibition

Score: 0.640 · neurodegeneration · 2026-04-02

## Mechanistic Overview Glycine-Rich Domain Competitive Inhibition starts from the claim that modulating TARDBP within t

Amyloid-beta induces secondary pericyte senescence after contractile and oxidati

Score: 0.640 · neurodegeneration · 2026-04-25

Soluble Aβ oligomers trigger endothelin-1 and ROS-dependent pericyte contractile stress, and repeated exposure converts

Enteric Nervous System Dysfunction as Self-Reinforcing Pathological Loop

Score: 0.630 · neurodegeneration · 2026-04-26

PD patients exhibit dual ENS pathology: α-synuclein aggregation within enteric neurons and progressive loss of cholinerg

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

Score: 0.630 · neurodegeneration · 2026-04-25

Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal

Steric Occlusion of G3BP1 Oligomerization Interface

Score: 0.630 · neurodegeneration · 2026-04-21

**Molecular Mechanism and Rationale** The hypothesis centers on the precise regulation of G3BP1 (Ras GTPase-activating

APOE4-microglial complement signaling causes cholinergic-enriched synaptic vulne

Score: 0.630 · neurodegeneration · 2026-04-25

APOE4 may bias microglia toward complement-mediated pruning that disproportionately strips vulnerable long-range choline

Circulating Soluble PDGFRβ Reflects Pericyte Loss and Precedes Cognitive Decline

Score: 0.625 · unknown disease · 2026-04-26

Soluble PDGFRβ (sPDGFRβ) is released into the bloodstream upon pericyte damage, serving as a peripheral indicator of blo